Cargando…

Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review

Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate, protein, and lipid metabolism, often accompanied by oxidative stress. Diabetes treatment is a complicated process in which, in addition to the standard pharmacological action, it is necessary to append a...

Descripción completa

Detalles Bibliográficos
Autores principales: Szałabska-Rąpała, Katarzyna, Borymska, Weronika, Kaczmarczyk-Sedlak, Ilona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467064/
https://www.ncbi.nlm.nih.gov/pubmed/34576213
http://dx.doi.org/10.3390/ijms221810050
_version_ 1784573301392146432
author Szałabska-Rąpała, Katarzyna
Borymska, Weronika
Kaczmarczyk-Sedlak, Ilona
author_facet Szałabska-Rąpała, Katarzyna
Borymska, Weronika
Kaczmarczyk-Sedlak, Ilona
author_sort Szałabska-Rąpała, Katarzyna
collection PubMed
description Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate, protein, and lipid metabolism, often accompanied by oxidative stress. Diabetes treatment is a complicated process in which, in addition to the standard pharmacological action, it is necessary to append a comprehensive approach. Introducing the aspect of non-pharmacological treatment of diabetes allows one to alleviate its many adverse complications. Therefore, it seems important to look for substances that, when included in the daily diet, can improve diabetic parameters. Magnolol, a polyphenolic compound found in magnolia bark, is known for its health-promoting activities and multidirectional beneficial effects on the body. Accordingly, the goal of this review is to systematize the available scientific literature on its beneficial effects on type 2 diabetes and its complications. Taking the above into consideration, the article collects data on the favorable effects of magnolol on parameters related to glycemia, lipid metabolism, or oxidative stress in the course of diabetes. After careful analysis of many scientific articles, it can be concluded that this lignan is a promising agent supporting the conventional therapies with antidiabetic drugs in order to manage diabetes and diabetes-related diseases.
format Online
Article
Text
id pubmed-8467064
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84670642021-09-27 Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review Szałabska-Rąpała, Katarzyna Borymska, Weronika Kaczmarczyk-Sedlak, Ilona Int J Mol Sci Review Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate, protein, and lipid metabolism, often accompanied by oxidative stress. Diabetes treatment is a complicated process in which, in addition to the standard pharmacological action, it is necessary to append a comprehensive approach. Introducing the aspect of non-pharmacological treatment of diabetes allows one to alleviate its many adverse complications. Therefore, it seems important to look for substances that, when included in the daily diet, can improve diabetic parameters. Magnolol, a polyphenolic compound found in magnolia bark, is known for its health-promoting activities and multidirectional beneficial effects on the body. Accordingly, the goal of this review is to systematize the available scientific literature on its beneficial effects on type 2 diabetes and its complications. Taking the above into consideration, the article collects data on the favorable effects of magnolol on parameters related to glycemia, lipid metabolism, or oxidative stress in the course of diabetes. After careful analysis of many scientific articles, it can be concluded that this lignan is a promising agent supporting the conventional therapies with antidiabetic drugs in order to manage diabetes and diabetes-related diseases. MDPI 2021-09-17 /pmc/articles/PMC8467064/ /pubmed/34576213 http://dx.doi.org/10.3390/ijms221810050 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Szałabska-Rąpała, Katarzyna
Borymska, Weronika
Kaczmarczyk-Sedlak, Ilona
Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review
title Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review
title_full Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review
title_fullStr Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review
title_full_unstemmed Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review
title_short Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review
title_sort effectiveness of magnolol, a lignan from magnolia bark, in diabetes, its complications and comorbidities—a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467064/
https://www.ncbi.nlm.nih.gov/pubmed/34576213
http://dx.doi.org/10.3390/ijms221810050
work_keys_str_mv AT szałabskarapałakatarzyna effectivenessofmagnololalignanfrommagnoliabarkindiabetesitscomplicationsandcomorbiditiesareview
AT borymskaweronika effectivenessofmagnololalignanfrommagnoliabarkindiabetesitscomplicationsandcomorbiditiesareview
AT kaczmarczyksedlakilona effectivenessofmagnololalignanfrommagnoliabarkindiabetesitscomplicationsandcomorbiditiesareview